173 related articles for article (PubMed ID: 6147145)
21. Disparate effects of the calcium-channel blockers, nifedipine and verapamil, on alpha 2-adrenergic receptors and thromboxane A2-induced aggregation of human platelets.
Johnson GJ; Leis LA; Francis GS
Circulation; 1986 Apr; 73(4):847-54. PubMed ID: 3004784
[TBL] [Abstract][Full Text] [Related]
22. Action mechanism of the platelet aggregation inducer and inhibitor from Echis carinatus snake venom.
Teng CM; Ma YH; Ouyang CH
Biochim Biophys Acta; 1985 Jul; 841(1):8-14. PubMed ID: 3926005
[TBL] [Abstract][Full Text] [Related]
23. Dicentrine, a novel antiplatelet agent inhibiting thromboxane formation and increasing the cyclic AMP level of rabbit platelets.
Yu SM; Chen CC; Ko FN; Huang YL; Huang TF; Teng CM
Biochem Pharmacol; 1992 Jan; 43(2):323-9. PubMed ID: 1310852
[TBL] [Abstract][Full Text] [Related]
24. Biphasic effect on platelet aggregation by phospholipase a purified from Vipera russellii snake venom.
Teng CM; Chen YH; Ouyang C
Biochim Biophys Acta; 1984 May; 772(3):393-402. PubMed ID: 6426517
[TBL] [Abstract][Full Text] [Related]
25. Competitive antagonism at thromboxane receptors in human platelets.
Armstrong RA; Jones RL; Peesapati V; Will SG; Wilson NH
Br J Pharmacol; 1985 Mar; 84(3):595-607. PubMed ID: 2580580
[TBL] [Abstract][Full Text] [Related]
26. Triphenyltin fluoride in vitro inhibition of rabbit platelet collagen-induced aggregation and ATP secretion and blockade of arachidonic acid mobilization from membrane phospholipids.
Manabe S; Wada O; Matsui H; Takada M; Kobayashi N; Maekawa T
Biochem Pharmacol; 1983 May; 32(10):1627-34. PubMed ID: 6305366
[TBL] [Abstract][Full Text] [Related]
27. Effects of suramin on increases in cytosolic calcium and on inhibition of adenylate cyclase induced by adenosine 5'-diphosphate in human platelets.
Hall DA; Hourani SM
Biochem Pharmacol; 1994 Mar; 47(6):1013-8. PubMed ID: 8147900
[TBL] [Abstract][Full Text] [Related]
28. Effect of the calcium-entry blocking agent nifedipine on activation of human platelets and comparison with verapamil.
Han P; Boatwright C; Ardlie NG
Thromb Haemost; 1983 Aug; 50(2):513-7. PubMed ID: 6314581
[TBL] [Abstract][Full Text] [Related]
29. Plasmin inhibition of platelet function and of arachidonic acid metabolism.
Schafer AI; Adelman B
J Clin Invest; 1985 Feb; 75(2):456-61. PubMed ID: 3156149
[TBL] [Abstract][Full Text] [Related]
30. Inhibitory effect of 8-bromo cyclic GMP on an extracellular Ca2+-dependent arachidonic acid liberation in collagen-stimulated rabbit platelets.
Matsuoka I; Nakahata N; Nakanishi H
Biochem Pharmacol; 1989 Jun; 38(11):1841-7. PubMed ID: 2544181
[TBL] [Abstract][Full Text] [Related]
31. Effects of activation of protein kinase C on the agonist-induced stimulation and inhibition of cyclic AMP formation in intact human platelets.
Williams KA; Murphy W; Haslam RJ
Biochem J; 1987 May; 243(3):667-78. PubMed ID: 2444206
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of platelet aggregation in whole blood by adrenoceptor antagonists.
Greer IA; Walker JJ; Calder AA; Forbes CD
Thromb Res; 1985 Dec; 40(5):631-43. PubMed ID: 3937284
[TBL] [Abstract][Full Text] [Related]
33. Acetyl glycerylphosphorylcholine inhibition of prostaglandin I2-stimulated adenosine 3',5'-cyclic monophosphate levels in human platelets. Evidence for thromboxane A2 dependence.
Miller OV; Ayer DE; Gorman RR
Biochim Biophys Acta; 1982 Jun; 711(3):445-51. PubMed ID: 6285985
[TBL] [Abstract][Full Text] [Related]
34. A defect of platelet release reaction in a patient with SLE: impaired platelet aggregation induced by phorbol ester with a normal phosphorylation of 40K protein.
Fuse I; Hattori A; Higashihara M; Takizawa S; Takeshige T; Hanano M; Nagayama R; Koike T; Takahashi H; Shibata A
Scand J Haematol; 1986 Jan; 36(1):44-54. PubMed ID: 3081995
[TBL] [Abstract][Full Text] [Related]
35. Beta 2-adrenergic regulation of prostaglandin D2 receptor in rabbit platelets.
Hanasaki K; Mizuno Y; Ikeda M; Shimonishi M; Yoshimura S; Tomita K; Ichikawa A
Biochim Biophys Acta; 1987 Feb; 927(2):261-8. PubMed ID: 2880608
[TBL] [Abstract][Full Text] [Related]
36. Antiplatelet effect of butylidenephthalide.
Teng CM; Chen WY; Ko WC; Ouyang CH
Biochim Biophys Acta; 1987 Jun; 924(3):375-82. PubMed ID: 3109495
[TBL] [Abstract][Full Text] [Related]
37. Influence of granulocyte elastase-like proteinase (ELP) on platelet functions.
Taki M; Miura T; Inagaki M; Tomita Y; Saito N; Okada Y; Tsuda Y; Meguro T; Yamada K
Thromb Res; 1986 Mar; 41(6):837-46. PubMed ID: 3010492
[TBL] [Abstract][Full Text] [Related]
38. Effect of the concentration of Ca2+ in the suspending medium on the responses of human and rabbit platelets to aggregating agents.
Packham MA; Bryant NL; Guccione MA; Kinlough-Rathbone RL; Mustard JF
Thromb Haemost; 1989 Nov; 62(3):968-76. PubMed ID: 2512683
[TBL] [Abstract][Full Text] [Related]
39. Platelet thromboxane synthesis and release reactions in myeloproliferative disorders.
Smith IL; Martin TJ
Haemostasis; 1982; 11(2):119-27. PubMed ID: 6211399
[TBL] [Abstract][Full Text] [Related]
40. Novel inhibitory actions on platelet thromboxane and inositolphosphate formation by xanthones and their glycosides.
Teng CM; Lin CN; Ko FN; Cheng KL; Huang TF
Biochem Pharmacol; 1989 Nov; 38(21):3791-5. PubMed ID: 2512926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
